Sep 8, 2015
Genzyme to Pay $32.5M to Resolve Criminal Liability Relating to Seprafilm
Genzyme Corporation, a wholly-owned biotechnology subsidiary of French pharmaceutical company Sanofi, agreed today to resolve criminal charges that it violated the federal Food, Drug and Cosmetic Act (FDCA) with regard to the unlawful distribution of Seprafilm, a surgical device it markets and promotes, the Justice Department announced. As part of the agreed resolution, the department…
Genzyme to Pay $32.5M to Resolve Criminal Liability Relating to Seprafilm was originally published on Allison Legal Law Firm